Back to Screener

Healthcare

U.S. Physical Therapy, Inc.(USPH)

Live Price

Offline

$65.79

+4.71% today

1Y Change

-13.02%

Window

Jun 23, 2025 โ†’ Jun 11, 2026

Market Cap
$1.09B
Revenue Growth
+16.3%
EPS Growth
-22.8%
Dividend Yield
2.5%

Coverage: 244 bars ยท Jun 23, 2025 โ†’ Jun 11, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

U.S. Physical Therapy, Inc. (USPH) is a Healthcare stock with a market cap of $1.09B and listed on NYSE. The stock last traded around $65.79 and down 13.0% across the available one-year price window (Jun 23, 2025 โ†’ Jun 11, 2026). Baseline metrics include revenue growth of +16.3%, EPS growth of -22.8%, a dividend yield of 2.5%. What stands out right now is revenue +16.3%, EPS -22.8%, free cash flow -7.2% with operating margin 13.4% and ROIC 6.1%. The dividend matters to the case here, with a current yield around 2.5%. Valuation already assumes a fairly strong business story at P/E 70.7 and price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines USPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+16.3% vs +7.6% peer median

Operating Margin

Below sector median

+13.4% vs +19.4% peer median

P/E

Above sector median

70.7 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 6, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at +16.3% and EPS is at -22.8%, with operating margin around 13.4%.

Shareholder return is still part of the story

The stock is still offering a dividend yield around 2.5%, which matters if the thesis depends on income as much as growth.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -11.0% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 6, 2026
โ€”-19.9%-18.3%-16.1%
2026
Feb 25, 2026
+0.0%-2.9%+3.0%-8.2%
2025
Nov 5, 2025
-1.5%-11.9%-17.6%-13.3%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

USPH

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

USPH Max Drawdown

-36.67%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for USPH and SPY.

Calendar-year return history is still loading or unavailable.
U.S. Physical Therapy, Inc. logo

Company Overview

U.S. Physical Therapy, Inc.

New York Stock Exchange

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Leadership
Christopher J. Reading
IPO Date
May 29, 1992
Employees
4.0k
Street Address
1300 West Sam Houston Parkway South
Mailing
Houston, TX, 77042
Region
Houston, TX, US
Reporting Currency
USD
Investor Line
713 297 7000
Last Updated
May 5, 2026
CIK: 0000885978ISIN: US90337L1089CUSIP: 90337L108
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
70.7
EV/EBITDA
13.5
Price/Sales
1.6
Price/Book
2.3

Growth

Revenue
+16.3%
EPS
-22.8%
Free Cash Flow
-7.2%

Profitability

Gross Margin
22.2%
Operating Margin
13.4%
Net Margin
2.3%
ROE
3.1%
ROIC
6.1%

Balance Sheet

Debt/Equity
0.89
Current Ratio
1.01

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 6, 26
โ€”
Est 0.55
โ€”
โ€”
Est 200940.6B
โ€”
โ€”
Feb 25, 26
โ€”
0.67
Est 0.67
0.0%
202726.0B
Est 199895.4B
+1.4%
โ€”
Nov 5, 25
โœ—
0.66
Est 0.67
-1.5%
164024.0B
Est 200099.4B
-18.0%
โ€”
Aug 6, 25
โœ“
0.81
Est 0.71
+14.1%
164183.0B
Est 189851.4B
-13.5%
โ€”
May 7, 25
โœ“
0.48
Est 0.46
+4.3%
152547.0B
Est 188180.2B
-18.9%
โ€”
Feb 26, 25
โœ—
0.65
Est 0.69
-5.8%
180447.0B
Est 173104.4B
+4.2%
โ€”
Nov 5, 24
โœ“
0.69
Est 0.68
+1.5%
168033.0B
Est 171855.2B
-2.2%
โ€”
Aug 13, 24
โœ—
0.73
Est 0.81
-9.9%
167190.0B
Est 162320.0B
+3.0%
โ€”
May 7, 24
โœ—
0.51
Est 0.56
-8.9%
155675.0B
Est 155675.0B
0.0%
โ€”
Feb 28, 24
โœ“
0.59
Est 0.57
+3.5%
154801.0B
Est 154801.0B
0.0%
โ€”
Nov 7, 23
โ€”
0.62
Est 0.62
0.0%
150007.0B
Est 148920.0B
+0.7%
โ€”
Aug 8, 23
โœ“
0.76
Est 0.75
+1.3%
151485.0B
Est 151060.0B
+0.3%
โ€”
May 3, 23
โœ“
0.59
Est 0.52
+13.5%
148509.0B
Est 140770.0B
+5.5%
โ€”
Feb 22, 23
โ€”
0.58
Est 0.58
0.0%
141182.0B
Est 141093.8B
+0.1%
โ€”
Nov 2, 22
โœ“
0.58
Est 0.56
+3.6%
139602.0B
Est 138030.2B
+1.1%
โ€”
Aug 4, 22
โœ—
0.90
Est 0.95
-5.3%
140656.0B
Est 143090.6B
-1.7%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.